Write a reviewFor vendors
♡
Home / Investors / Martin Heidecker

Martin Heidecker

Corporate VC · Cambridge

About Martin Heidecker

Corporate venture investor (Chief Investment Officer) based in Cambridge, Massachusetts. Focus areas include Health Care, Research and Development, Hospitals. Invests at seed stage. Past investments include Aignostics, T3 Pharmaceuticals, Dopavision.

Investment focus

Stages
Seed
Sectors
Health CareResearch and DevelopmentHospitalsWellnessWomen FoundedAntibioticsHealthcare InnovationChemicalEngineeringHealth Care PolicyArtificial Intelligence (AI)Venture FundraisingFinanceSoftwareBiotechnologyDrug DevelopmentCosmeticsClinical TrialsResearchHealth Diagnostics

Portfolio

No portfolio companies recorded yet; Martin Heidecker reports 46 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Nash

Angel Investor · Los Altos
SeedPre-SeedAdvertisingData IntegrationTelecommunicationsE-commerce+16
60Investments
—Exits